Analysis of chondroitin/dermatan sulfate microstructure in cultured vascular smooth muscle cells after exposure to lead and cadmium

Journal of Health Science

Volumn 49, Issue 6, 2003, Pages 534-540

  Fujiwara, Yasuyuki ^a   Yamamoto, Chika ^a   Kaji, Toshiyuki ^a   Plaas, Anna H ^b  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Atherosclerosis; Cadmium; Glycosaminoglycan; Lead; Proteoglycan; Vascular smooth muscle cell

Indexed keywords

CADMIUM; CHONDROITIN SULFATE; DERMATAN SULFATE; GLUCURONIC ACID; IDURONIC ACID; LEAD; N ACETYLGALACTOSAMINE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL CULTURE; CELL DENSITY; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CONTROLLED STUDY; EXPOSURE; NONHUMAN; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALIA;

EID: 24744435342     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.49.534     Document Type: Article

References (29)

1. Iozzo, R. V. (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol., 32, 141-174.
2. Camejo, G., Hurt-Camejo, E., Wiklund, O. and Bondjers, G. (1998) Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis. Atherosclerosis, 139, 205-222.
3. Whinna, H. C., Choi, H. U., Rosenberg, L. C. and Church, F. C. (1993) Interaction of heparin cofactor II with biglycan and decorin. J. Biol. Chem., 268, 3920-3924.
4. Järveläinen, H. T., Kinsella, M. G., Wight, T. N. and Sandell, L. J. (1991) Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem., 266, 23274-23281.
5. Wight, T. N., Heinegard, D. K. and Hascall, V. C. (1991) Proteoglycans: structure and function. In Cell Biology of Extracellular Matrix, 2nd ed. (Hay, E. D., Ed.), Plenum Press, NY, pp. 45-78.
6. Silbert, J. E. (1996) Organization of glycosaminoglycan sulfation in the biosynthesis of proteochondroitin sulfate and proteodermatan sulfate. Glycoconj. J., 13, 907-912.
7. Dingwall-Fordyce, I. and Lane, R. E. (1963) A follow-up study of lead workers. Br. J. Ind. Med., 20, 313-315.
8. Houtman, J. R. (1993) Prolonged low-level cadmium intake and atherosclerosis. Sci. Total Environ., 138, 31-36.
9. Revis, N. W., Zinsmeister, A. R. and Bull, R. (1981) Atherosclerosis and hypertension induced by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. U.S.A., 78, 6494-6498.
10. Subramanyam, G., Bhaskar, M. and Govindappa, S. (1992) The role of cadmium in induction of atherosclerosis in rabbits. Indian Heart J., 44, 177-180.
11. Yamamoto, C. and Kaji, T. (2002) Induction of plasminogen activator inhibitor type 1 synthesis by cadmium in human vascular endothelial cells in culture. J. Health Sci., 48, 55-61.
12. Kaji, T., Mishima, A., Yamamoto, C., Sakamoto, M. and Koizumi, F. (1992) Effect of cadmium on the monolayer maintenance of vascular endothelial cells in culture. Toxicology, 98, 105-110.
13. Ross, R., Glomset, J. and Harker, L. (1997) Response to injury and atherosclerosis. Am. J. Pathol., 86, 675-684.
14. Fujiwara, Y. and Kaji, T. (1999) Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Toxicology, 133, 159-169.
15. Fujiwara, Y. and Kaji, T. (2002) Suppression of proteoglycan synthesis by calcium ionophore A23187 in cultured vascular endothelial cells: Implication of intracellular calcium accumulation in lead inhibition of endothelial proteoglycan synthesis. J. Health Sci., 48, 460-466.
16. Fujiwara, Y. and Kaji, T. (2000) Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sci., 46, 1-4.
17. Fujiwara, Y., Kaji, T., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995) Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells. Toxicology, 98, 105-110.
18. Fujiwara, Y., Watanabe, S. and Kaji, T. (1998) Promotion of cultured vascular smooth muscle cell proliferation by low levels of cadmium. Toxicol. Lett., 94, 175-180.
19. Yamamoto, C., Kaji, T., Sakamoto, M. and Kozuka, H. (1996) Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from cultured human vascular smooth muscle cells and fibroblasts. Toxicology, 106, 179-185.
20. Yamamoto, C., Miyamoto, A., Sakamoto, M. and Kaji, T. (1997) Lead perturbs the regulation of spontaneous release of tissue plasminogen activator and plasminogen activator inhibitor-1 from vascular smooth muscle cells and fibroblasts in culture. Toxicology, 117, 153-161.
21. Fujiwara, Y., Yamamoto, C. and Kaji, T. (2000) Proteoglycans synthesized by cultured bovine aortic smooth muscle cells after exposure to lead: lead selectively inhibits the synthesis of versican, a large chondroitin sulfate proteoglycan. Toxicology, 154, 9-19.
22. Fujiwara, Y., Tsumura, N., Yamamoto, C. and Kaji, T. (2002) Different effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extracellular matrix at low cell density. Toxicology, 170, 89-101.
23. Jackson, P. (1994) High resolution polyacrylamide gel electrophoresis of fluorophore-labeled reducting saccharides. Meth. Enzymol., 230, 250-265.
24. Plaas, A. H., West, L. A. and Midura, R. J. (2001) Keratan sulfate disaccharide composition determined by FACE analysis of keratanase II and endobeta-galactosidase digestion products. Glycobiology, 11, 779-790.
25. Gutierrez, P., O'Brien, K. D., Ferguson, M., Nikkari, S. T., Alpers, C. E. and Wight, T. N. (1997) Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc. Pathol., 6, 271-278.
26. Shirk, R. A., Parthasarathy, N., San Antonio, J. D., Church, F. C. and Wagner, W. D. (2000) Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J. Biol. Chem., 275, 18085-18092.
27. Schönherr, E., Jörveläinen, H. T., Sandell, L. J. and Wight, T. N. (1991) Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem., 266, 17640-17647.
28. Schönherr, E., Järveläinen, H. T., Kinsella, M. G., Sandell, L. J. and Wight, T. N. (1993) Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb., 13, 1026-1036.
29. Kaji, T., Hiraga, S., Yamamoto, C., Fujiwara, Y., Ueda, Y., Zisaki, F., Iwata, K., Okada, Y. and Katsuda, S. (2002) Effect of tumor necrosis factor-α on the synthesis of DNA, the secretion of matrix metalloproteinases/tissue inhibitors of metalloproteinases, and the activity of invasive migration in cultured vascular smooth muscle cells. J. Health Sci., 48, 354-358.